Literature DB >> 35475206

Unusual cause of a polypoid lesion in the extrahepatic bile duct.

Yu Bin Tan1, Lai Mun Wang2, Andrew B E Kwek1.   

Abstract

Adenomyomas are benign lesions that are most frequently found in the gallbladder but can also be rarely found in the biliary tract. Although benign, they present close similarity to malignant lesions and thus deserve important clinical consideration. We present a case of a 74-year-old Chinese man who presented acutely with fever and painless obstructive jaundice. CT imaging showed a large calculus within a dilated common bile duct (CBD) and, despite undergoing an endoscopic retrograde cholangiopancreatography (ERCP) with stone clearance, there was a persistent filling defect that was adherent to the wall of the proximal common bile duct. His CA 19-9 was also significantly raised. Intraductal ultrasonography (IDUS) showed a polypoid mass with papillary-like projections, and ERCP forcep biopsies were unable to exclude a lesion with neoplastic potential. The patient subsequently underwent cholecystectomy with open CBD excision and Roux-en-Y hepaticojejunostomy, and histology showed features consistent with a biliary adenomyoma.
© 2022 The Authors. JGH Open published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  biliary adenomyoma; biliary polyp; common bile duct

Year:  2022        PMID: 35475206      PMCID: PMC9021710          DOI: 10.1002/jgh3.12739

Source DB:  PubMed          Journal:  JGH Open        ISSN: 2397-9070


Introduction

Adenomyomas can be found most commonly in the gallbladder but also in other parts of the GI tract such as the stomach, duodenum, and jejunum. Biliary adenomyoma are extremely rare and appear as duct‐like structures with smooth muscle hyperplasia, possibly arising from heterotopic pancreatic tissue and in the presence of reactive inflammatory changes related to gallstones. Though commonly seen in the gallbladder as adenomyomatosis, it is also seen affecting the ampulla of Vater and, rarely, in the extrahepatic bile duct.

Case Report

A 74‐year‐old Chinese man presented to our hospital acutely with fever and painless obstructive jaundice. Although appearing deeply icteric, his abdomen was soft and non‐tender. Laboratory investigations showed serum bilirubin 212 μmol/L, alkaline phosphatase 462 U/L, and alanine transaminase 180 U/L. CT imaging showed a large calculus within the distal common bile duct (CBD). It also revealed a smaller intraluminal focus located more proximally within the CBD, likely representing a second calculus or possibly a polyp given its antidependent position (Fig. 1a). He was started on ceftriaxone and metronidazole, and the pre‐procedure serum carcino embryonic antigen was 2.13 μg/L and serum CA 19–9 was 1392 U/mL.
Figure 1

(a) CT image showing a large calculus within the distal common bile duct (CBD) and a smaller intraluminal focus located more proximally within the CBD, likely representing a second calculus or possibly a polyp given its antidependent position. (b) Cholangiogram showing a persistent filling defect that was adherent to the wall of the proximal common bile duct. (c) Intraductal ultrasonography (IDUS) showing a polypoid mass with papillary‐like projections. (d) Cross‐sectional macroscopic examination showing a 1.4‐cm polypoid lesion within the CBD. Microscopic examination of the H&E‐stained slide at low power (20×), showing fibromuscular wall thickening with intramural diverticula or duct‐like spaces. (e) Higher magnification (100×) image showing benign lobular arrangement of biliary glands in association with adjacent smooth‐muscle hyperplasia. Overall, the features are consistent with biliary adenomyoma. (f) A medium (40×) magnification image of the intraluminal polypoid prolapsed portion of the adenomyoma mimicking a neoplastic lesion of the biliary tract.

(a) CT image showing a large calculus within the distal common bile duct (CBD) and a smaller intraluminal focus located more proximally within the CBD, likely representing a second calculus or possibly a polyp given its antidependent position. (b) Cholangiogram showing a persistent filling defect that was adherent to the wall of the proximal common bile duct. (c) Intraductal ultrasonography (IDUS) showing a polypoid mass with papillary‐like projections. (d) Cross‐sectional macroscopic examination showing a 1.4‐cm polypoid lesion within the CBD. Microscopic examination of the H&E‐stained slide at low power (20×), showing fibromuscular wall thickening with intramural diverticula or duct‐like spaces. (e) Higher magnification (100×) image showing benign lobular arrangement of biliary glands in association with adjacent smooth‐muscle hyperplasia. Overall, the features are consistent with biliary adenomyoma. (f) A medium (40×) magnification image of the intraluminal polypoid prolapsed portion of the adenomyoma mimicking a neoplastic lesion of the biliary tract. He underwent endoscopic retrograde cholangiopancreatography (ERCP) and stone fragments were removed with balloon and Dormia basket trawls, but larger stone fragments were not removed because of distal narrowing. Decision was made to stage the procedure because of prolonged procedure time, and a 10‐Fr 8‐cm plastic biliary stent was placed. He underwent a repeat ERCP 2 weeks later with balloon dilation of the papilla and distal CBD, and remnant stones were extracted with the basket and balloon. A final cholangiogram showed no CBD stones but there was a persistent filling defect that was adherent to the wall of the proximal CBD (Fig. 1b). Intraductal ultrasonography (IDUS) was performed, which showed a polypoid mass with papillary‐like projections (Fig. 1c). ERCP forcep biopsy specimens taken from the mass revealed the presence of columnar‐lined epithelium with no features of high‐grade dysplasia or malignancy. However, a biliary mass lesion with neoplastic potential could not be excluded. He subsequently underwent a cholecystectomy with open CBD excision and Roux‐en‐Y hepaticojejunostomy. On cross‐sectional macroscopic examination of the resected specimen, a 1.4‐cm polypoid lesion was identified within the CBD. Microscopic examination of the H&E‐stained slide at low (20×) magnification revealed fibromuscular wall thickening with intramural diverticula or duct‐like spaces (Fig. 1d), and higher magnification (100×) images showed benign lobular arrangement of biliary glands in association with adjacent smooth muscle hyperplasia (Fig. 1e). Overall, the features were consistent with biliary adenomyoma. At medium (40×) magnification, image of the intraluminal polypoid prolapsed portion of the adenomyoma mimicked a neoplastic lesion of the biliary tract (Fig. 1f).

Discussion

The incidence of biliary adenomyoma is hard to estimate because of the various terminologies used to refer to the same type of lesion. Terms such as adenomyomatosis, adenomyomatous hyperplasia, adenomyosis, or adenomyoma have been used interchangeably. Suffice to say, it is exceedingly rare with an estimated 4 out of 22 000 surgical cases reported at Mayo clinic in a paper published in 1932. A more recent literature review on this topic by Gouveia et al. in 2021 described only 61 cases of biliary adenomyoma in the medical literature, with most cases published as single case reports. A further breakdown of these cases showed that CBD adenomyoma, such as in this case, is much rarer with only 12 such cases (20% of all biliary adenomyoma) reported in the literature. The pathophysiology of biliary adenomyoma is still unclear. Four possible hypotheses have been suggested. The most commonly accepted one, which is recognized by the WHO, is that these lesions may represent a form of incomplete heterotopic pancreas tissue. This “misplaced” pancreatic tissue could have stimulated secondary muscular proliferation, thus distorting the normal architecture of the biliary tree. Another hypothesis is that these lesions develop in diverticula from reactive muscle hyperplasia and secondary gland formation. Yet another hypothesis suggests that adenomyoma may have developed as a result of fibroadenomatous changes due to aging. Finally, chronic inflammation such as CBD stones and cholangitis may have also resulted in the reactive muscle hyperplasia that forms such adenomyomas. Based on current evidence, biliary adenomyomas are not considered to be malignant or have malignant potential. Bile duct adenomyoma is rarely diagnosed preoperatively, as cross‐sectional imaging characteristics are not specific enough to differentiate them from other neoplastic lesions. Similarly, endosonographic features may be nonspecific and, when performed, ERCP forcep biopsies may not be adequate to show the prominent smooth muscle bundles. Indeed, the sensitivity of brush cytology and intraductal biopsy in diagnosing malignant biliary strictures is 45 and 48.1%, respectively, and both techniques are almost 100% specific. Combining both modalities increases the sensitivity to 59.4%. Even when localized to the more accessible location of the ampulla of Vater, biopsies were diagnostic only in 62% of patients. One way to overcome the limitation of the diagnostic yield would be to repeat the ERCP forceps biopsy, as it has been shown that a repeated negative biopsy result for malignancy reduces the chance of a malignant lesion to less than 10%. Intraoperative frozen section is another tool that may be used to differentiate such lesions and to decide on the extent of surgery required. Additionally, when suspected, immunohistochemistry evaluation showing cytokeratin 7 expression, no cytokeratin 20 expression, and low proliferative activity (Ki67) would differentiate benign adenomyomas from neoplastic adenomas or carcinomas. As this mass lesion is frequently associated with obstructive jaundice and mimics a neoplastic lesion, invasive surgery often follows. Importantly, it is noted that the recurrence rate of such benign lesions (22%) is 4 times greater after local excision compared to a more radical procedure. In our patient, the raised serum CA 19–9 made the suspicion for a neoplastic lesion even higher, although on hindsight, the raised CA 19–9 was likely related to cholangitis. Following biliary drainage surgery, our patient made a complete recovery with resolution of symptoms and jaundice.
  7 in total

1.  Analysis of false-negative diagnoses on endoscopic brush cytology of biliary and pancreatic duct strictures: the experience at 2 university hospitals.

Authors:  R Logrono; D F Kurtycz; C P Molina; V A Trivedi; J Y Wong; K P Block
Journal:  Arch Pathol Lab Med       Date:  2000-03       Impact factor: 5.534

2.  [Lesions of the area of Oddi's sphincter: incidence and association with biliary and pancreatic lesions in a series of 109 autopsies].

Authors:  E D Martin; P Bedossa; P Oudinot
Journal:  Gastroenterol Clin Biol       Date:  1987 Aug-Sep

3.  Benign neoplasms of the extrahepatic biliary ducts.

Authors:  R Burhans; R T Myers
Journal:  Am Surg       Date:  1971-03       Impact factor: 0.688

4.  Tumors of the papilla of Vater--inadequate diagnostic impact of endoscopic forceps biopsies taken prior to and following sphincterotomy.

Authors:  J Menzel; C Poremba; K H Dietl; W Böcker; W Domschke
Journal:  Ann Oncol       Date:  1999-10       Impact factor: 32.976

Review 5.  Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis.

Authors:  Udayakumar Navaneethan; Basile Njei; Vennisvasanth Lourdusamy; Rajesh Konjeti; John J Vargo; Mansour A Parsi
Journal:  Gastrointest Endosc       Date:  2014-11-01       Impact factor: 9.427

6.  Adenomyomatosis of the Common Bile Duct and Ampulla of Vater.

Authors:  Catarina Gouveia; Catarina Fidalgo; Rui Loureiro; Helena Oliveira; Rui Maio; Marília Cravo
Journal:  GE Port J Gastroenterol       Date:  2020-09-02

7.  Adenomyoma and adenomyomatous hyperplasia of the Vaterian system: clinical, pathological, and new immunohistochemical features of 13 cases.

Authors:  Adriana Handra-Luca; Benoit Terris; Anne Couvelard; Helene Bonte; Jean-François Flejou
Journal:  Mod Pathol       Date:  2003-06       Impact factor: 7.842

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.